| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adult weight change and the risk of pre- and postmenopausal breast cancer in the Chinese Wuxi Exposure and Breast Cancer Study
|
Cao, Shang
|
|
2018
|
173 |
3 |
p. 647-655
|
artikel
|
| 2 |
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention
|
Walter, Katherine R.
|
|
2018
|
173 |
3 |
p. 559-571
|
artikel
|
| 3 |
Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women
|
Yoon, Tae In
|
|
2018
|
173 |
3 |
p. 657-665
|
artikel
|
| 4 |
Association between pre-operative magnetic resonance imaging (MRI) and surgical outcomes in breast cancer: not yet determined
|
Xu, Ran
|
|
2018
|
173 |
3 |
p. 749-750
|
artikel
|
| 5 |
A systematic review of interventions to improve adherence to endocrine therapy
|
Heiney, Sue P.
|
|
2018
|
173 |
3 |
p. 499-510
|
artikel
|
| 6 |
Clinical implication of E-cadherin deficiency in lobular breast cancer
|
Corso, Giovanni
|
|
2018
|
173 |
3 |
p. 751-752
|
artikel
|
| 7 |
Clinical subtypes and prognosis in breast cancer according to parity: a nationwide study in Korean Breast Cancer Society
|
Park, Sungmin
|
|
2018
|
173 |
3 |
p. 679-691
|
artikel
|
| 8 |
Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis
|
Rodrigues-Ferreira, Sylvie
|
|
2018
|
173 |
3 |
p. 573-583
|
artikel
|
| 9 |
Concordance with BRCA1/2 testing guidelines among women in The Health of Women (HOW) Study®
|
Silver, Michelle I.
|
|
2018
|
173 |
3 |
p. 719-726
|
artikel
|
| 10 |
CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines
|
Drögemöller, Britt I.
|
|
2018
|
173 |
3 |
p. 521-532
|
artikel
|
| 11 |
Impact of pre-diagnosis depressive symptoms and health-related quality of life on treatment choice for ductal carcinoma in situ and stage I breast cancer in older women
|
Buscariollo, Daniela L.
|
|
2018
|
173 |
3 |
p. 709-717
|
artikel
|
| 12 |
Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues
|
Heng, Yujing J.
|
|
2018
|
173 |
3 |
p. 667-677
|
artikel
|
| 13 |
PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer
|
Ohara, Ako Matsushita
|
|
2018
|
173 |
3 |
p. 533-543
|
artikel
|
| 14 |
Predictive value of lymphoscintigraphy in patients with breast cancer-related lymphedema undergoing complex decongestive therapy
|
Kim, Young Hwan
|
|
2018
|
173 |
3 |
p. 735-741
|
artikel
|
| 15 |
Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer
|
Xue, Cong
|
|
2018
|
173 |
3 |
p. 619-628
|
artikel
|
| 16 |
Quantitative comparison of drug efficacy in treating hot flashes in patients with breast cancer
|
Li, Ting
|
|
2018
|
173 |
3 |
p. 511-520
|
artikel
|
| 17 |
Racial disparities in breast cancer persist despite early detection: analysis of treatment of stage 1 breast cancer and effect of insurance status on disparities
|
Hoppe, Ethan J.
|
|
2018
|
173 |
3 |
p. 597-602
|
artikel
|
| 18 |
Racial/ethnic disparities in inflammatory breast cancer survival in the Michigan Cancer Surveillance Program
|
Gudina, Abdi T.
|
|
2018
|
173 |
3 |
p. 693-699
|
artikel
|
| 19 |
Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer
|
Vallet, Sonia
|
|
2018
|
173 |
3 |
p. 585-596
|
artikel
|
| 20 |
Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals
|
Szostakowska, Małgorzata
|
|
2018
|
173 |
3 |
p. 489-497
|
artikel
|
| 21 |
Survivorship care visits in a high-risk population of breast cancer survivors
|
Skuli, Sarah J.
|
|
2018
|
173 |
3 |
p. 701-708
|
artikel
|
| 22 |
The flaxseed lignan secoisolariciresinol diglucoside decreases local inflammation, suppresses NFκB signaling, and inhibits mammary tumor growth
|
Bowers, Laura W.
|
|
2018
|
173 |
3 |
p. 545-557
|
artikel
|
| 23 |
The intron 3 16 bp duplication polymorphism of p53 (rs17878362) is not associated with increased risk of developing triple-negative breast cancer
|
Morten, Brianna C.
|
|
2018
|
173 |
3 |
p. 727-733
|
artikel
|
| 24 |
Treatment delays from transfers of care and their impact on breast cancer quality measures
|
Bleicher, Richard J.
|
|
2018
|
173 |
3 |
p. 603-617
|
artikel
|
| 25 |
Trends in stage at diagnosis for young breast cancer patients in the United States
|
DeSantis, Carol E.
|
|
2018
|
173 |
3 |
p. 743-747
|
artikel
|
| 26 |
Type 2 diabetes as a predictor of survival among breast cancer patients: the multiethnic cohort
|
Maskarinec, Gertraud
|
|
2018
|
173 |
3 |
p. 637-645
|
artikel
|
| 27 |
YouTube English videos as a source of information on breast self-examination
|
Esen, Ebru
|
|
2018
|
173 |
3 |
p. 629-635
|
artikel
|
Tijdschrift beschrijving